PAHC
Phibro Animal Health CorporationNASDAQHealthcare$55.52+1.39%ClosedMarket Cap: $2.25B
As of 2026-04-06
Valuation
P/E (TTM)
24.44
PEG
0.06
P/B
6.70
P/S
1.52
EV/EBITDA
13.03
DCF Value
$-14.14
FCF Yield
2.1%
Div Yield
0.9%
Margins & Returns
Gross Margin
31.9%
Operating Margin
11.6%
Net Margin
6.3%
ROE
30.8%
ROA
6.6%
ROIC
10.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $373.9M | 35.5% | $54.4M | $27.5M | $0.67 | $0.12 |
| Q1 2026 | $363.9M | 32.9% | $47.9M | $26.5M | $0.65 | $0.12 |
| Q4 2025 | $378.7M | 29.0% | $33.7M | $17.2M | $0.42 | $0.12 |
| FY 2025 | $1.30B | 30.9% | $110.5M | $48.3M | $1.19 | $0.48 |
| Q3 2025 | $347.8M | 30.1% | $33.5M | $20.9M | $0.51 | $0.12 |
| Q2 2025 | $309.3M | 32.9% | $25.5M | $3.2M | $0.08 | $0.12 |
| Q1 2025 | $260.4M | 32.1% | $17.7M | $7.0M | $0.17 | $0.12 |
| Q4 2024 | $273.2M | 31.9% | $18.4M | $752.0K | $0.02 | $0.12 |
| FY 2024 | $1.02B | 30.8% | $53.3M | $2.4M | $0.06 | $0.48 |
| Q3 2024 | $263.2M | 30.2% | $19.9M | $8.4M | $0.21 | $0.12 |
| Q2 2024 | $249.9M | 31.5% | $15.7M | $1.3M | $0.03 | $0.12 |
| Q1 2024 | $231.3M | 29.3% | $-726.0K | $-8.0M | $-0.20 | $0.12 |